Download from app store
We have detected that you are using an Ad Blocker.
PracticeUpdate is free to end users but we rely on advertising to fund our site. Please consider supporting PracticeUpdate by whitelisting us in your ad blocker.
We have sent a message to the email address you have provided, . If this email is not correct, please update your settings with your correct address.
The email address you provided during registration, , does not appear to be valid. Please update your settings with a valid address before to continue using PracticeUpdate.
Please provide your AHPRA Number to ensure that you are given the correct level of access to our site.
Published in Oncology

Journal Scan / Research · February 26, 2022

Blinatumomab and POMP Maintenance in Older Patients With Newly Diagnosed Ph-Negative B-ALL

Journal of Clinical Oncology


Additional Info

Journal of Clinical Oncology
SWOG 1318: A Phase II Trial of Blinatumomab Followed by POMP Maintenance in Older Patients With Newly Diagnosed Philadelphia Chromosome-Negative B-Cell Acute Lymphoblastic Leukemia
J. Clin. Oncol 2022 Feb 14;[EPub Ahead of Print], AS Advani, A Moseley, KM O'Dwyer, BL Wood, M Fang, MJ Wieduwilt, I Aldoss, JH Park, RB Klisovic, MR Baer, W Stock, RR Bhave, M Othus, RC Harvey, CL Willman, MR Litzow, RM Stone, E Sharon, HP Erba

From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine.

Further Reading